Tissue factor at the crossroad of coagulation and cell signaling

The tissue factor (TF) pathway plays a central role in hemostasis and thrombo‐inflammatory diseases. Although structure‐function relationships of the TF initiation complex are elucidated, new facets of the dynamic regulation of TF's activities in cells continue to emerge. Cellular pathways that render TF non‐coagulant participate in signaling of distinct TF complexes with associated proteases through the protease‐activated receptor (PAR) family of G protein‐coupled receptors. Additional co‐receptors, including the endothelial protein C receptor (EPCR) and integrins, confer signaling specificity by directing subcellular localization and trafficking. We here review how TF is switched between its role in coagulation and cell signaling through thiol‐disulfide exchange reactions in the context of physiologically relevant lipid microdomains. Inflammatory mediators, including reactive oxygen species, activators of the inflammasome, and the complement cascade play pivotal roles in TF procoagulant activation on monocytes, macrophages and endothelial cells. We furthermore discuss how TF, intracellular ligands, co‐receptors and associated proteases are integrated in PAR‐dependent cell signaling pathways controlling innate immunity, cancer and metabolic inflammation. Knowledge of the precise interactions of TF in coagulation and cell signaling is important for understanding effects of new anticoagulants beyond thrombosis and identification of new applications of these drugs for potential additional therapeutic benefits.

[1]  P. Wilgenbus,et al.  Paraoxonase-2 regulates coagulation activation through endothelial tissue factor. , 2018, Blood.

[2]  K. Lackner,et al.  Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies. , 2018, Blood advances.

[3]  S. Lacroix-Desmazes,et al.  Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies , 2018, JCI insight.

[4]  M. Goumans,et al.  Structural and cellular mechanisms of peptidyl-prolyl isomerase Pin1-mediated enhancement of Tissue Factor gene expression, protein half-life, and pro-coagulant activity , 2018, Haematologica.

[5]  José A Fernández,et al.  PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. , 2018, Blood.

[6]  U. Eriksson,et al.  Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity , 2018, Cardiovascular research.

[7]  W. Ruf,et al.  Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling. , 2018, Blood.

[8]  B. Engelmann,et al.  Distinct Pathogenesis of Pancreatic Cancer Microvesicle–Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Maraveyas,et al.  Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles. , 2018, Biochimica et biophysica acta. Molecular cell research.

[10]  U. Pendurthi,et al.  The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system. , 2017, Blood advances.

[11]  E. Soule,et al.  A novel protein C–factor VII chimera provides new insights into the structural requirements for cytoprotective protease‐activated receptor 1 signaling , 2017, Journal of thrombosis and haemostasis : JTH.

[12]  A. Gruber,et al.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex. , 2017, Blood.

[13]  G. Gilliland,et al.  Crystal structure of tissue factor in complex with antibody 10H10 reveals the signaling epitope. , 2017, Cellular signalling.

[14]  J. Luyendyk,et al.  Thrombin promotes diet-induced obesity through fibrin-driven inflammation , 2017, The Journal of clinical investigation.

[15]  M. Mayr,et al.  Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease , 2017, The Journal of experimental medicine.

[16]  R. Pawlinski,et al.  Prothrombotic aspects of sickle cell disease , 2017, Journal of thrombosis and haemostasis : JTH.

[17]  W. Ruf,et al.  Tissue Factor Prothrombotic Activity Is Regulated by Integrin-arf6 Trafficking , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[18]  U. Pendurthi,et al.  Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding. , 2017, Blood advances.

[19]  P. Sen,et al.  Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression , 2017, The Journal of Biological Chemistry.

[20]  Patrik Johansson,et al.  Structural insight into allosteric modulation of protease-activated receptor 2 , 2017, Nature.

[21]  Jian Yu,et al.  FVIIa prevents the progressive hemorrhaging of a brain contusion by protecting microvessels via formation of the TF–FVIIa–FXa complex , 2017, Neuroscience.

[22]  K. Jurk,et al.  Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. , 2017, Blood.

[23]  A. Mast,et al.  Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State. , 2017, Blood advances.

[24]  D. Neuberg,et al.  Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. , 2017, JCI insight.

[25]  J. Trejo,et al.  Challenges and Opportunities in Protease-Activated Receptor Drug Development. , 2017, Annual review of pharmacology and toxicology.

[26]  Tomiki Sumiyoshi,et al.  Role of , 2017 .

[27]  C. Craik,et al.  Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling. , 2016, Blood.

[28]  Y. Miyagi,et al.  High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors , 2015, Thrombosis and Haemostasis.

[29]  W. Desmet,et al.  Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium† , 2015, European heart journal.

[30]  José A Fernández,et al.  Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice. , 2015, Blood.

[31]  N. Mackman,et al.  Regulation of alveolar procoagulant activity and permeability in direct acute lung injury by lung epithelial tissue factor. , 2015, American journal of respiratory cell and molecular biology.

[32]  A. Balduini,et al.  Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation , 2015, Thrombosis and Haemostasis.

[33]  A. Mast,et al.  New insights into the biology of tissue factor pathway inhibitor , 2015, Journal of thrombosis and haemostasis : JTH.

[34]  J. Griffin,et al.  EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. , 2015, Blood.

[35]  W. Ruf,et al.  Caspase-1-mediated pathway promotes generation of thromboinflammatory microparticles. , 2015, The Journal of clinical investigation.

[36]  A. Giatromanolaki,et al.  Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction , 2015, European heart journal.

[37]  W. Ruf,et al.  Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice. , 2015, The American journal of pathology.

[38]  J. Griffin,et al.  THROMBOSIS AND HEMOSTASIS EPCR-dependent PAR 2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice , 2015 .

[39]  C. Lecut,et al.  P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice. , 2014, Blood.

[40]  J. Bergquist,et al.  The Eph Tyrosine Kinase Receptors EphB2 and EphA2 Are Novel Proteolytic Substrates of Tissue Factor/Coagulation Factor VIIa* , 2014, The Journal of Biological Chemistry.

[41]  C. Esmon,et al.  Endothelial cell protein C receptor: a multiliganded and multifunctional receptor. , 2014, Blood.

[42]  T. Renné,et al.  Factor XII Regulates the Pathological Process of Thrombus Formation on Ruptured Plaques , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[43]  A. Akhmedov,et al.  Alternatively Spliced Tissue Factor Is Not Sufficient for Embryonic Development , 2014, PloS one.

[44]  C. Esmon,et al.  Factor VIIa binding to endothelial cell protein C receptor protects vascular barrier integrity in vivo , 2014, Journal of thrombosis and haemostasis : JTH.

[45]  T. Nakano,et al.  Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma , 2014, Cell Death and Disease.

[46]  N. Mackman,et al.  Multiple roles of the coagulation protease cascade during virus infection. , 2014, Blood.

[47]  W. Ruf,et al.  Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation , 2014, Thrombosis and Haemostasis.

[48]  A. Siegbahn,et al.  Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor , 2013, Thrombosis and Haemostasis.

[49]  A. Maraveyas,et al.  Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles , 2013, Thrombosis and Haemostasis.

[50]  A. Ibrahim,et al.  Acute myocardial infarction. , 2014, Critical care clinics.

[51]  D. Milewicz,et al.  Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα. , 2013, The Journal of clinical investigation.

[52]  T. van der Poll,et al.  Factor Xa Activation of Factor V Is of Paramount Importance in Initiating the Coagulation System: Lessons From a Tick Salivary Protein , 2013, Circulation.

[53]  P. Reitsma,et al.  Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner , 2013, Proceedings of the National Academy of Sciences.

[54]  C. Bokemeyer,et al.  Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. , 2013, Blood.

[55]  A. Maraveyas,et al.  p38α phosphorylates serine 258 within the cytoplasmic domain of tissue factor and prevents its incorporation into cell-derived microparticles. , 2013, Biochimica et biophysica acta.

[56]  W. Ruf,et al.  Inflammation, obesity, and thrombosis. , 2012, Blood.

[57]  A. Girod,et al.  Autophagy Mediates the Delivery of Thrombogenic Tissue Factor to Neutrophil Extracellular Traps in Human Sepsis , 2012, PloS one.

[58]  T. Renné,et al.  Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. , 2012, Blood.

[59]  A. Walch,et al.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.

[60]  F. Bäckhed,et al.  Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling , 2012, Nature.

[61]  B. Aronow,et al.  Splice variants of tissue factor promote monocyte‐endothelial interactions by triggering the expression of cell adhesion molecules via integrin‐mediated signaling , 2011, Journal of thrombosis and haemostasis : JTH.

[62]  W. Ruf,et al.  Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation , 2011, Nature Medicine.

[63]  A. Gruber,et al.  P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. , 2011, The Journal of clinical investigation.

[64]  A. Bohm,et al.  Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins , 2011, Proceedings of the National Academy of Sciences.

[65]  H. Versteeg,et al.  Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. , 2010, Blood.

[66]  C. Esmon,et al.  The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors* , 2010, The Journal of Biological Chemistry.

[67]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[68]  K. Preissner,et al.  Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases , 2010, Nature Medicine.

[69]  E. Tajkhorshid,et al.  Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor , 2010, Journal of thrombosis and haemostasis : JTH.

[70]  O. Olsen,et al.  Engineering of Substrate Selectivity for Tissue Factor·Factor VIIa Complex Signaling through Protease-activated Receptor 2* , 2010, The Journal of Biological Chemistry.

[71]  L. Rydén,et al.  Evidence for tissue factor phosphorylation and its correlation with protease‐activated receptor expression and the prognosis of primary breast cancer , 2009, International journal of cancer.

[72]  E. Jordanova,et al.  Alternatively spliced tissue factor induces angiogenesis through integrin ligation , 2009, Proceedings of the National Academy of Sciences.

[73]  Christine M. Miller,et al.  Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. , 2009, Blood.

[74]  A. Abo,et al.  rNAPc2 Inhibits Colorectal Cancer in Mice through Tissue Factor , 2009, Clinical Cancer Research.

[75]  W. Ruf,et al.  Spectroscopic Characterization of Successive Phosphorylation of the Tissue Factor Cytoplasmic Region. , 2009, The open spectroscopy journal.

[76]  M. Hollenberg,et al.  Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction , 2008, Journal of Biological Chemistry.

[77]  Julia L. Gregory,et al.  The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed‐type hypersensitivity , 2008, Journal of leukocyte biology.

[78]  Nigel Mackman,et al.  Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. , 2008, The Journal of clinical investigation.

[79]  Y. Takada,et al.  Hemostasis, Thrombosis, and Vascular Biology: Inhibition of tissue factor signaling suppresses tumor growth , 2014 .

[80]  W. Ruf,et al.  Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. , 2007, Blood.

[81]  W. Ruf,et al.  Role of Protease Activated Receptor 1 and 2 Signaling in Hypoxia-Induced Angiogenesis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[82]  B. Engelmann,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2006 .

[83]  Nigel Mackman,et al.  Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets , 2006, The Journal of experimental medicine.

[84]  H. Versteeg,et al.  Disulfide isomerization switches tissue factor from coagulation to cell signaling , 2006, Proceedings of the National Academy of Sciences.

[85]  H. Versteeg,et al.  Emerging insights in tissue factor-dependent signaling events. , 2006, Seminars in thrombosis and hemostasis.

[86]  T. Renné,et al.  Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.

[87]  C. Esmon,et al.  Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin , 2005, Journal of thrombosis and haemostasis : JTH.

[88]  M. Belting,et al.  Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. , 2005, Blood.

[89]  Y. Takada,et al.  Cross-talk of integrin α3β1 and tissue factor in cell migration , 2004 .

[90]  H. Prydz,et al.  The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells , 2004, Thrombosis and Haemostasis.

[91]  W. Ruf,et al.  Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic Domain* , 2004, Journal of Biological Chemistry.

[92]  P. Carmeliet,et al.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.

[93]  W. Ruf,et al.  Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. , 2003, Blood.

[94]  A. Olson,et al.  The tissue factor/factor VIIa/factor Xa complex: A model built by docking and site‐directed mutagenesis , 2003, Proteins.

[95]  Y. Nemerson,et al.  Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein , 2003, Nature Medicine.

[96]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[97]  W. Ruf,et al.  Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[98]  W. Ruf,et al.  Role of Zymogen and Activated Factor X as Scaffolds for the Inhibition of the Blood Coagulation Factor VIIa-Tissue Factor Complex by Recombinant Nematode Anticoagulant Protein c2* , 2001, The Journal of Biological Chemistry.

[99]  S. Coughlin,et al.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Y. Miyagi,et al.  Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[101]  Y. Miyagi,et al.  A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280 , 1998, The Journal of cell biology.

[102]  T S Edgington,et al.  The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. , 1998, Journal of molecular biology.

[103]  H. Gilbert,et al.  Protein disulfide isomerase. , 1998, Methods in enzymology.

[104]  A. Rehemtulla,et al.  Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII. , 1992, The Journal of biological chemistry.

[105]  Florey,et al.  The endothelial cell. , 1966, British medical journal.